Citigroup’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.6M Buy
1,025,000
+910,000
+791% +$70.1M 0.03% 505
2025
Q4
$9.13M Sell
115,000
-35,000
-23% -$2.76M ﹤0.01% 1604
2025
Q3
$11.3M Sell
150,000
-156,000
-51% -$10.7M 0.01% 1395
2025
Q2
$21.1M Buy
306,000
+106,000
+53% +$6.95M 0.01% 932
2025
Q1
$13.6M Buy
200,000
+49,000
+32% +$2.93M 0.01% 1177
2024
Q4
$6.78M Buy
+151,000
New +$8.47M ﹤0.01% 1677
2024
Q1
Sell
-382,500
Closed -$30.2M 5673
2023
Q4
$30.2M Buy
382,500
+75,000
+24% +$5.34M 0.02% 665
2023
Q3
$21.5M Sell
307,500
-242,500
-44% -$17.2M 0.02% 743
2023
Q2
$38M Buy
550,000
+103,500
+23% +$7.36M 0.02% 547
2023
Q1
$33.2M Buy
446,500
+252,500
+130% +$21.2M 0.02% 571
2022
Q4
$18.1M Sell
194,000
-120,000
-38% -$11.6M 0.01% 848
2022
Q3
$29.9M Sell
314,000
-110,000
-26% -$10.9M 0.02% 584
2022
Q2
$39.3M Sell
424,000
-100,000
-19% -$9.76M 0.03% 474
2022
Q1
$53M Sell
524,000
-114,800
-18% -$12.1M 0.03% 473
2021
Q4
$65.9M Sell
638,800
-11,200
-2% -$1.03M 0.04% 456
2021
Q3
$55.2M Buy
650,000
+540,000
+491% +$45.2M 0.03% 487
2021
Q2
$9.18M Buy
110,000
+30,000
+38% +$2.46M 0.01% 1481
2021
Q1
$6.02M Sell
80,000
-402,514
-83% -$29.3M ﹤0.01% 1665
2020
Q4
$33M Sell
482,514
-20,300
-4% -$1.32M 0.02% 751
2020
Q3
$29.4M Buy
502,814
+57,500
+13% +$3.58M 0.02% 710
2020
Q2
$28.9M Sell
445,314
-9,800
-2% -$617K 0.02% 627
2020
Q1
$27M Sell
455,114
-154,846
-25% -$10.3M 0.02% 588
2019
Q4
$45.3M Buy
609,960
+94,121
+18% +$6.61M 0.03% 548
2019
Q3
$32.5M Sell
515,839
-700,858
-58% -$41.5M 0.03% 647
2019
Q2
$66.3M Sell
1,216,697
-98,550
-7% -$5.31M 0.05% 345
2019
Q1
$70.9M Buy
1,315,247
+595,123
+83% +$36.7M 0.07% 268
2018
Q4
$47.2M Buy
720,124
+129,324
+22% +$9.65M 0.05% 421
2018
Q3
$46.5M Sell
590,800
-116,300
-16% -$8.31M 0.04% 420
2018
Q2
$45.5M Sell
707,100
-100,700
-12% -$6.64M 0.04% 394
2018
Q1
$50.3M Sell
807,800
-103,300
-11% -$7.41M 0.04% 387
2017
Q4
$66.1M Buy
911,100
+606,600
+199% +$44.1M 0.05% 341
2017
Q3
$24.8M Buy
304,500
+55,300
+22% +$4.37M 0.02% 704
2017
Q2
$20.1M Sell
249,200
-194,800
-44% -$15.4M 0.02% 749
2017
Q1
$34.9M Buy
444,000
+81,600
+23% +$6.51M 0.03% 505
2016
Q4
$28.6M Buy
362,400
+134,700
+59% +$10.9M 0.03% 589
2016
Q3
$20.3M Buy
227,700
+32,600
+17% +$3.08M 0.02% 688
2016
Q2
$18.7M Buy
195,100
+21,200
+12% +$2.11M 0.02% 678
2016
Q1
$18M Sell
173,900
-115,600
-40% -$11.2M 0.02% 648
2015
Q4
$28.3M Sell
289,500
-301,500
-51% -$29.5M 0.03% 577
2015
Q3
$57M Buy
591,000
+435,000
+279% +$45.7M 0.05% 313
2015
Q2
$16.4M Sell
156,000
-8,900
-5% -$909K 0.01% 902
2015
Q1
$17M Sell
164,900
-53,800
-25% -$5.44M 0.02% 863
2014
Q4
$21.1M Buy
218,700
+65,000
+42% +$5.73M 0.02% 775
2014
Q3
$12.2M Sell
153,700
-99,200
-39% -$7.82M 0.01% 1134
2014
Q2
$19.1M Buy
252,900
+13,300
+6% +$1.01M 0.02% 827
2014
Q1
$17.9M Sell
239,600
-57,800
-19% -$4.08M 0.02% 786
2013
Q4
$21.3M Buy
297,400
+28,500
+11% +$1.83M 0.02% 733
2013
Q3
$15.3M Buy
268,900
+56,000
+26% +$3.34M 0.01% 867
2013
Q2
$12.2M Buy
+212,900
New +$12.3M 0.01% 949

Other funds holding CVS

Citigroup's CVS Position: Q1 2026 in Review

Citigroup increased its CVS Health (CVS) stake by 25% in Q1 2026, buying an estimated $30.7M and bringing the position to 1,986,793 shares worth $143M. The position accounts for 0.06% of the portfolio, ranked #293.

Citigroup first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $341M in Q1 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Citigroup held 1,986,793 shares of CVS Health worth $143M as of Q1 2026.
  • Citigroup bought 398,103 CVS Health shares in Q1 2026, an estimated $30.7M.
  • CVS Health made up 0.06% of Citigroup's portfolio in Q1 2026, its #293 holding.
  • Citigroup first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's CVS Health position peaked at $341M in Q1 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.